Objective: To evaluate the ability of health-related quality of life (HRQOL
) measures to detect change over time in persons with epilepsy. Background:
The application of HRQOL measures in clinical trials has been limited by a
dearth of information regarding their abilities to measure change over tim
e (i.e., their responsiveness). To calculate responsiveness, one must categ
orize subjects as "changed" or "unchanged" by a priori criteria. Methods: T
he authors analyzed data collected at baseline and at 28-week follow-up fro
m an antiepileptic drug trial. Two different criteria for classifying subje
cts as changed or unchanged-one based on seizure frequency (where changed =
attainment of seizure freedom) and one based on self-reported overall cond
ition (where changed = improvement in overall condition)-were used. We comp
ared responsiveness indices for two generic (Short Form [SF]-36 and SF-12)
and two epilepsy-targeted (Quality of Life in Epilepsy [QOLIE]-89 and QOLIE
-31) HRQOL measures. Two scoring procedures for the SF-36, one based on cla
ssic test theory and the other on item response theory (IRT), were compared
. Results: Effect sizes of the most responsive HRQOL measures were medium t
o large. The shorter epilepsy-targeted measure had similar responsiveness i
ndices to those of the longer measure. Epilepsy-targeted measures were cons
istently more responsive than generic measures under the overall condition
criterion, but for the seizure freedom criterion, IRT scoring of the SF-36
yielded responsiveness indices comparable to those of the epilepsy-targeted
measures. Conclusion: Epilepsy-targeted health-related quality of life mea
sures may be preferable to generic ones in longitudinal studies. Selection
of a shorter epilepsy-targeted measure does not compromise responsiveness.
Item response theory scoring should be applied to epilepsy-targeted HRQOL m
easures.